Khaled M. Harmouch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Khaled M. Harmouch has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Mohamed Chadi Alraies
Detroit Medical Center Detroit Michigan USA
2 shared publications - Alaa Roto
Department of Internal Medicine, DMC Sinai Grace, Wayne State School of Medicine, Detroit, USA
1 shared publication - George G. Kidess
Wayne State University School of Medicine, Detroit, MI, USA
1 shared publication - Jawad Basit
Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan
1 shared publication - Matthew T. Brennan
Wayne State University School of Medicine, Detroit, Michigan, USA
1 shared publication - Mohammad Hamza
Department of Internal Medicine, Albany Medical Center, Albany, NY 12208, USA
1 shared publication
Latest Publications
- 19 December 2024
- Published by Springer Nature in American Journal of Cardiovascular Drugs
- Vol. 25 (3) , 389-398
Morphine and P2Y12 Inhibitors in ST-Elevation Myocardial Infarction: An Updated Meta-Analysis
Background Morphine is used to control pain in ST-elevation myocardial infarction but reduces P2Y12 inhibition. It is not known if this modulation of platelet inhibition appreciably affects clinical outcomes. Methods We screened 979 articles and identified seven studies that met the eligibility criteria for meta-analysis. Outcomes included 11 metrics across angiographic and clinical domains. A random effects model assessed heterogeneity between studies. Results The opiate group showed decreased achievement of postprocedural thrombolysis in myocardial infarction (TIMI) 2 flow relative to placebo [risk ratio (RR) 0.71, 95% confidence interval (CI) 0.52–0.97, p = 0.03, I2 = 0.0%]. All other metrics listed below showed no statistically significant difference between groups: infarct size, microvascular obstruction, microvascular/salvage index, absence of pre- percutaneous coronary intervention (PCI) TIMI 3 flow, postprocedural TIMI 2 flow, postprocedural TIMI 3 flow, all-cause mortality, stroke, repeat MI, unstable angina, and left ventricular ejection fraction. However, there were no statistically significant differences in infarct size [odds ratio (OR) − 0.12, 95% CI − 0.37 to 0.17, p = 0.42], microvascular obstruction [standard mean difference (SMD) = 0.02, 95% CI − 0.12 to 0.16, p = 0.82], microvascular obstruction/salvage index (SMD = − 0.05, 95% CI − 0.24 to 0.13, p = 0.57), absence of pre-PCI TIMI 3 flow (OR 0.98, 95% CI 0.79–1.22, p = 0.87), and postprocedural TIMI 3 flow (OR 1.23, 95% CI 0.84–1.79, p = 0.28) between the two groups. Conclusions In STEMI, opiates correlate with worse angiographic outcomes, specifically postprocedural TIMI 2 flow. However, this observation does not appear to be clinically consequential.
- 19 December 2024
- Published by Springer Nature in American Journal of Cardiovascular Drugs
- Vol. 25 (3) , 389-398
Morphine and P2Y12 Inhibitors in ST-Elevation Myocardial Infarction: An Updated Meta-Analysis
Background Morphine is used to control pain in ST-elevation myocardial infarction but reduces P2Y12 inhibition. It is not known if this modulation of platelet inhibition appreciably affects clinical outcomes. Methods We screened 979 articles and identified seven studies that met the eligibility criteria for meta-analysis. Outcomes included 11 metrics across angiographic and clinical domains. A random effects model assessed heterogeneity between studies. Results The opiate group showed decreased achievement of postprocedural thrombolysis in myocardial infarction (TIMI) 2 flow relative to placebo [risk ratio (RR) 0.71, 95% confidence interval (CI) 0.52–0.97, p = 0.03, I2 = 0.0%]. All other metrics listed below showed no statistically significant difference between groups: infarct size, microvascular obstruction, microvascular/salvage index, absence of pre- percutaneous coronary intervention (PCI) TIMI 3 flow, postprocedural TIMI 2 flow, postprocedural TIMI 3 flow, all-cause mortality, stroke, repeat MI, unstable angina, and left ventricular ejection fraction. However, there were no statistically significant differences in infarct size [odds ratio (OR) − 0.12, 95% CI − 0.37 to 0.17, p = 0.42], microvascular obstruction [standard mean difference (SMD) = 0.02, 95% CI − 0.12 to 0.16, p = 0.82], microvascular obstruction/salvage index (SMD = − 0.05, 95% CI − 0.24 to 0.13, p = 0.57), absence of pre-PCI TIMI 3 flow (OR 0.98, 95% CI 0.79–1.22, p = 0.87), and postprocedural TIMI 3 flow (OR 1.23, 95% CI 0.84–1.79, p = 0.28) between the two groups. Conclusions In STEMI, opiates correlate with worse angiographic outcomes, specifically postprocedural TIMI 2 flow. However, this observation does not appear to be clinically consequential.
- 5 April 2024
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (6) , 102560
Spontaneous coronary artery dissection: A review of medical management approaches
- 5 April 2024
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (6) , 102560
Spontaneous coronary artery dissection: A review of medical management approaches